Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer. Issue 1 (December 2016)
- Main Title:
- Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer
- Authors:
- Carbognin, Luisa
Sperduti, Isabella
Brunelli, Matteo
Marcolini, Lisa
Nortilli, Rolando
Pilotto, Sara
Zampiva, Ilaria
Merler, Sara
Fiorio, Elena
Filippi, Elisa
Manfrin, Erminia
Pellini, Francesca
Bonetti, Franco
Pollini, Giovanni
Tortora, Giampaolo
Bria, Emilio - Abstract:
- Abstract Background The aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery. Methods Clinical-pathological data were correlated with disease-free and overall survival (DFS/OS). The maximally selected Log-Rank statistics analysis was applied to the Ki67 continuous variable to estimate appropriate cut-offs. The Subpopulation Treatment Effect Pattern Plot (STEPP) analysis was performed to assess the interaction between 'pure' or 'mixed' histology ILC and Ki67. Results At a median follow-up of 67 months, 10-years DFS and OS of 405 patients were 67.8 and 79.8 %, respectively. Standardized Log-Rank statistics identified 2 optimal cut-offs (6 and 21 %); 10-years DFS and OS were 75.1, 66.5, and 30.2 % (p = 0.01 ) and 84.3, 76.4 and 59 % (p = 0.003 ), for patients with a Ki67 < 6 %, between 6 and 21 %, and >21 %, respectively. Ki67 and lymph-node status were independent predictor for longer DFS and OS at the multivariate analysis, with radiotherapy (for DFS) and age (for OS). Ki67 highly replicated at the internal cross-validation analysis (DFS 85 %, OS 100 %). The STEPP analysis showed that DFS rate decreases as Ki67 increases and those patients with 'pure' ILC performed worse than 'mixed' histology. Conclusions Despite the retrospective and exploratory nature of the study, Ki67 was able to significantly discriminate the prognosis of patients with ILC, and theAbstract Background The aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery. Methods Clinical-pathological data were correlated with disease-free and overall survival (DFS/OS). The maximally selected Log-Rank statistics analysis was applied to the Ki67 continuous variable to estimate appropriate cut-offs. The Subpopulation Treatment Effect Pattern Plot (STEPP) analysis was performed to assess the interaction between 'pure' or 'mixed' histology ILC and Ki67. Results At a median follow-up of 67 months, 10-years DFS and OS of 405 patients were 67.8 and 79.8 %, respectively. Standardized Log-Rank statistics identified 2 optimal cut-offs (6 and 21 %); 10-years DFS and OS were 75.1, 66.5, and 30.2 % (p = 0.01 ) and 84.3, 76.4 and 59 % (p = 0.003 ), for patients with a Ki67 < 6 %, between 6 and 21 %, and >21 %, respectively. Ki67 and lymph-node status were independent predictor for longer DFS and OS at the multivariate analysis, with radiotherapy (for DFS) and age (for OS). Ki67 highly replicated at the internal cross-validation analysis (DFS 85 %, OS 100 %). The STEPP analysis showed that DFS rate decreases as Ki67 increases and those patients with 'pure' ILC performed worse than 'mixed' histology. Conclusions Despite the retrospective and exploratory nature of the study, Ki67 was able to significantly discriminate the prognosis of patients with ILC, and the effect was more pronounced for patients with 'pure' ILC. … (more)
- Is Part Of:
- Journal of experimental & clinical cancer research. Volume 35:Issue 1(2016)
- Journal:
- Journal of experimental & clinical cancer research
- Issue:
- Volume 35:Issue 1(2016)
- Issue Display:
- Volume 35, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 35
- Issue:
- 1
- Issue Sort Value:
- 2016-0035-0001-0000
- Page Start:
- 1
- Page End:
- 9
- Publication Date:
- 2016-12
- Subjects:
- Lobular -- Breast cancer -- Ki67
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://rave.ohiolink.edu/ejournals/issn/17569966/ ↗
http://www.jeccr.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=618&action=archive ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13046-016-0325-z ↗
- Languages:
- English
- ISSNs:
- 1756-9966
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10020.xml